Plain-English translation of NCT07169019 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether adding probiotics—beneficial bacteria supplements—to (the standard first-line treatment for psoriasis) helps improve outcomes in people newly diagnosed with the condition. Researchers want to see if probiotics change the bacteria in your gut in ways that make the treatment work better and reduce psoriasis symptoms more effectively than alone.
Psoriasis is an autoimmune condition where the body's immune system attacks the skin, and is the standard treatment. However, researchers believe that the bacteria living in your gut may play a role in how well this medication works, so this trial explores whether adding probiotics could enhance treatment results.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either alone or plus daily probiotics for 16 weeks. You'll visit the clinic regularly for blood tests to monitor your liver and kidney function, and your skin will be assessed and photographed to measure how much your psoriasis improves. You'll also provide stool samples at the start and end of the study so researchers can analyze how the bacteria in your gut changes with treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt